Following the hedgehog to new cancer therapies.
Dlugosz
Andrzej A
AA
Talpaz
Moshe
M
D000813:Anilides; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D000072079:Patched Receptors; D011725:Pyridines; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D012878:Skin Neoplasms / Q000188:drug therapy
D000813:Anilides; D000970:Antineoplastic Agents; D001562:Benzimidazoles; D053823:Hedgehog Proteins; C538724:HhAntag691; D000072079:Patched Receptors; D011725:Pyridines; D011956:Receptors, Cell Surface